Source,TTY

 1  NIC93RT|           C0085671] [NOCODE]~----~drug abuse resistance education (
 2  NIC93RT|           C0150556] [NOCODE]~----~drug abuse treatment [C0150557] [
 3  NIC93RT|           C0150557] [NOCODE]~----~drug teaching [C0150558] [NOCODE]~----~
 4  NIC93RT|           C0150558] [NOCODE]~----~drug therapy [C0013216] [NOCODE]~----~
 5  NIC96AC|  drug-specific antidotes when the drug that was used is known [
 6  NIC96AC|  Administer lactation suppression drug, if appropriate [C0508282] [
 7  NIC96AC|      appropriate concentration of drug to fluid, considering the
 8  NIC96AC|           U001299]~----~Check for drug allergies [C0509368] [U001300]~----~
 9  NIC96AC|                Check for possible drug and IV incompatibilities [
10  NIC96AC|                Check for possible drug interactions and contraindications [
11  NIC96AC|                 Check history for drug allergies [C0509368] [U001313]~----~
12  NIC96AC|           Check medical order for drug, dose, and frequency of
13  NIC96AC| Collaborate with the physician if drug, dose, route of administration,
14  NIC96AC|        doubts about an unfamiliar drug or dose that is prescribed [
15  NIC96AC|    determine the best form of the drug to administer via the nasogastric
16  NIC96AC|         with representatives from drug companies, as appropriate [
17  NIC96AC|              Determine history of drug/alcohol use [C0509958] [
18  NIC96AC|          whether an overdose of a drug or other substance is involved [
19  NIC96AC|           amount and frequency of drug dosing, and response to
20  NIC96AC|       antineoplastic drugs during drug preparation and administration [
21  NIC96AC|       Identify amount and type of drug or combination of drugs
22  NIC96AC|           stomatitis secondary to drug therapy [C0511764] [U003724]~----~
23  NIC96AC|           the patient of possible drug/food interactions, as appropriate [
24  NIC96AC|      school policy that prohibits drug and alcohol consumption
25  NIC96AC|      U004639]~----~Label IVs with drug name and dosage [C0512670] [
26  NIC96AC|             Monitor antiepileptic drug levels, as appropriate [
27  NIC96AC|     Monitor blood pressure during drug therapy for lactation suppression [
28  NIC96AC|             U005066]~----~Monitor drug infusion at regular intervals [
29  NIC96AC|             U005067]~----~Monitor drug regimen [C0513082] [U005068]~----~
30  NIC96AC|        for adverse effects of the drug [C0513162] [U005152]~----~
31  NIC96AC|        Monitor for nontherapeutic drug interactions [C0513316] [
32  NIC96AC|         for signs and symptoms of drug toxicity [C0513384] [U005379]~----~
33  NIC96AC|         effects, adverse effects, drug toxicity, and drug interactions [
34  NIC96AC|       effects, drug toxicity, and drug interactions [C0513604] [
35  NIC96AC|  equipment and techniques for the drug administration modality [
36  NIC96AC|             Recognize that trough drug levels are useful for demonstrating
37  NIC96AC|        changes in the alcohol and drug curricula for primary grades [
38  NIC96AC|    U007411]~----~Refer patient to drug dependency treatment program,
39  NIC96AC|          noting duration, type of drug(s) used (including alcohol),
40  NIC96AC|      family members the method of drug administration, as appropriate [
41  NIC96AC|            U008420]~----~Use peak drug levels when testing for
42  NIC96AC|          before administering the drug [C0516457] [U008538]~----~
43  NIC96AC|        U008577]~----~Withdraw the drug gradually during detoxification [
44  NIC96HC|          and physiological crises~Drug Management [C0262754] [H]~
45  NIC96PT|     Prevention of an alcoholic or drug use lifestyle~Substance
46  NIC96PT|          Substance Use Treatment: Drug Withdrawal [C0150361] [4514]~
47  NIC96PT|         of a patient experiencing drug detoxification~Substance
48  NIC96SA|          on history, prescription drug use, ethnic background,
49  NIC96SA|         proper formulation of the drug is used [C0511019] [U002971]~----~
50  NOC97ID|      consequences associated with drug misuse [C0518297] [190402]~----~
51  NOC97ID|             Acknowledges risk for drug misuse [C0518296] [190401]~----~
52  NOC97ID|   C0518537] [030904]~----~Adjusts drug use control strategies as
53  NOC97ID|           190307]~----~Commits to drug use control strategies [
54  NOC97ID|             140217]~----~Controls drug intake [C0518307] [190416]~----~
55  NOC97ID|                Develops effective drug use control strategies [
56  NOC97ID|     190308]~----~Follows selected drug use control strategies [
57  NOC97ID|           for factors encouraging drug misuse [C0518298] [190403]~----~
58  NOC97ID|                 Monitors personal drug use patterns [C0518299] [
59  NOC97ID|    community resources to control drug misuse [C0518306] [190413]~----~
60  NOC97ID|        support systems to control drug misuse [C0518304] [190411]~----~
61  NOC97ID|         support groups to control drug misuse [C0518305] [190412]~----~
62  NOC97OC|           to health~Risk Control: Drug Use [C0518295] [1904]~Actions
63  NOC97OC|    Actions to eliminate or reduce drug use that poses a threat
64 PCDS97GO|           will experience minimal drug toxicity. [C0548621] [GOL_
65 PCDS97OR|       impact of alcohol and other drug use on patient's life. [
66 PCDS97OR|         of the patient with acute drug or alcohol withdrawal. [
67 PCDS97OR|        patient education plan for drug overdose. [C0548199] [ORC_
68 PCDS97OR|         for signs and symptoms of drug toxicity due to prolongation
69 PCDS97OR|      order and urine specimen for drug abuse. [C0547883] [ORC_11050.
70 PCDS97PR|           consciousness caused by drug ingestion [C0548850] [PRB_
71 PCDS97PR|       output alteration caused by drug ingestion [C0548826] [PRB_